Remarkable immunostimulation effects of hybrid liposomes on human peripheral blood mononuclear cells in vitro

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 3, 2007, Pages 613-616

  Komizu, Yuji ^a   Tomonaga, Yuka ^a   Goto, Koichi ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Hybrid liposome; IFN ; IL 12; Immunopotentiation; Peripheral blood mononuclear cell

Indexed keywords

ETHER DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 12; LIPOSOME; POLYOXYETHYLENE 25 DODECANOL ETHER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; HYBRID; IMMUNITY; IMMUNOSTIMULATION; IN VITRO STUDY; MALE; MEMBRANE FUSION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADJUVANTS, IMMUNOLOGIC; ADULT; CELL COUNT; CYTOKINES; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LIPOSOMES; MALE; MICROSCOPY, FLUORESCENCE; MONOCYTES; POLYETHYLENE GLYCOLS;

EID: 33846203432     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.11.010     Document Type: Article

References (23)

1. Douglas T.F., and Richard M.L. Science 272 (1996) 50
2. Torchilin V.P. Nat. Rev. Drug. Discov. 4 (2005) 145
3. Okamoto M., Gohda H., Yoshida H., Matsuno T., Saito M., and Sato M. J. Immunother. 23 (2000) 94
4. Barbara M., Sameersingh G.R., Sean C.S., and Michael J.H. J. Pharmacol. Exp. Ther. 298 (2001) 1185
5. Christina L.B., Christopher R.P., Caroline D., Warwick J.B., and Joseph G.A. Cancer Res. 64 (2004) 4257
6. Ueoka R., Matsumoto Y., Moss R.A., Swarup S., Sugii A., Harada K., Kikuchi J., and Murakami Y. J. Am. Chem. Soc. 110 (1988) 1588
7. Matsumoto Y., Imamura C., Ito T., Taniguchi C., and Ueoka R. Biol. Pharm. Bull. 18 (1995) 1456
8. Nakano K., Iwamoto Y., Takata W., Matsumoto Y., and Ueoka R. Bioorg. Med. Chem. Lett. 12 (2002) 3251
9. Nagami H., Nakano K., Ichihara H., Matsumoto Y., and Ueoka R. Bioorg. Med. Chem. Lett. 16 (2006) 782
10. Ueoka R., Matsumoto Y., Kanno A., Tsuzaki K., and Ichihara H. Biol. Pharm. Bull. 23 (2000) 1262
11. Ueoka R., Matsumoto Y., Ichihara H., and Kiyokawa T. In: Marten M.R., Park T.H., and Nagamune T. (Eds). Am. Chem. Soc. Symposium Series 830. Chemotherapy with hybrid liposomes composed of dimyristoylphosphatidylcholine and polyoxyethylenealkyl ether without drugs (2002), Am. Chem. Soc. Books, Washington 177
12. Matsumoto Y., Iwamoto Y., Matsushita T., and Ueoka R. Int. J. Cancer. 115 (2005) 377
13. Iwamoto Y., Matsumoto Y., and Ueoka R. Int. J. Pharm. 292 (2005) 231
14. Nagami H., Matsumoto Y., and Ueoka R. Int. J. Pharm. 315 (2006) 167
15. Nagami H., Yamamoto K., Ichihara H., Matsumoto Y., and Ueoka R. J. Chem. Eng. Jpn 36 (2003) 1127
16. Tominaga H., Ishiyama M., Ohseto F., Sasamoto K., Hamamoto T., Suzuki K., and Watanabe M. Anal. Commun. 36 (1999) 47
17. Refaeli Y., Parijs L.V., Alexander S.I., and Abbas A.K. J. Exp. Med. 196 (2002) 999
18. Liu Y., and Janeway Jr. C.A. J. Exp. Med. 172 (1990) 1735
19. Lohman B.L., and Welsh R.M. J. Virol. 72 (1998) 7815
20. Trinchieri G. Nat. Rev. Immunol. 3 (2003) 133
21. Kitamura I., Kochi M., Matsumoto Y., Ueoka R., Kuratsu J., and Ushio Y. Cancer Res. 56 (1996) 3986
22. Komizu Y., Matsumoto Y., and Ueoka R. Bioorg. Med. Chem. Lett. 16 (2006) 6131
23. Liebes L.F., Pelle E., Zucker-Franklin D., and Silber R. Cancer Res. 41 (1981) 4050